Cargando…
A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strai...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592754/ https://www.ncbi.nlm.nih.gov/pubmed/28869227 http://dx.doi.org/10.4103/lungindia.lungindia_451_16 |
_version_ | 1783262934663692288 |
---|---|
author | Kumar, Ankit Verma, Ajay Kumar Kant, Surya Prakash, Ved Srivastava, Anand Srivastava, Kanchan Jain, Amita Srivastava, Kishore K |
author_facet | Kumar, Ankit Verma, Ajay Kumar Kant, Surya Prakash, Ved Srivastava, Anand Srivastava, Kanchan Jain, Amita Srivastava, Kishore K |
author_sort | Kumar, Ankit |
collection | PubMed |
description | BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strains among MDR patients of pulmonary TB in Lucknow and surrounding areas. MATERIALS AND METHODS: It was a hospital-based epidemiological study. Our study population was selected from all the newly diagnosed patients attending outpatient department and admitted patients of Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India. Those isolates which were characterized to be MTB by morphological and molecular techniques were tested for their resistance against the first-line drugs; after which each patient's isolate was genotyped. RESULTS: The results suggested that the presence of Beijing genotype in 31.78% of strains. CONCLUSION: Our results predicted that genotypic patterns reveal a large diversity among the MTB Beijing strain population. Increasing frequency of Beijing strains demands further research to unravel the factors behind its propensity to prevail. |
format | Online Article Text |
id | pubmed-5592754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55927542017-09-19 A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis Kumar, Ankit Verma, Ajay Kumar Kant, Surya Prakash, Ved Srivastava, Anand Srivastava, Kanchan Jain, Amita Srivastava, Kishore K Lung India Original Article BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strains among MDR patients of pulmonary TB in Lucknow and surrounding areas. MATERIALS AND METHODS: It was a hospital-based epidemiological study. Our study population was selected from all the newly diagnosed patients attending outpatient department and admitted patients of Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India. Those isolates which were characterized to be MTB by morphological and molecular techniques were tested for their resistance against the first-line drugs; after which each patient's isolate was genotyped. RESULTS: The results suggested that the presence of Beijing genotype in 31.78% of strains. CONCLUSION: Our results predicted that genotypic patterns reveal a large diversity among the MTB Beijing strain population. Increasing frequency of Beijing strains demands further research to unravel the factors behind its propensity to prevail. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5592754/ /pubmed/28869227 http://dx.doi.org/10.4103/lungindia.lungindia_451_16 Text en Copyright: © 2017 Indian Chest Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumar, Ankit Verma, Ajay Kumar Kant, Surya Prakash, Ved Srivastava, Anand Srivastava, Kanchan Jain, Amita Srivastava, Kishore K A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title | A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title_full | A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title_fullStr | A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title_full_unstemmed | A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title_short | A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
title_sort | study on beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592754/ https://www.ncbi.nlm.nih.gov/pubmed/28869227 http://dx.doi.org/10.4103/lungindia.lungindia_451_16 |
work_keys_str_mv | AT kumarankit astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT vermaajaykumar astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT kantsurya astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT prakashved astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavaanand astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavakanchan astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT jainamita astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavakishorek astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT kumarankit studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT vermaajaykumar studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT kantsurya studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT prakashved studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavaanand studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavakanchan studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT jainamita studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis AT srivastavakishorek studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis |